Search by Drug Name or NDC

    NDC 70934-0717-30 Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1 Details

    Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1

    Lisinopril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. dba Northwind Pharmaceuticals. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.

    Product Information

    NDC 70934-0717
    Product ID 70934-717_a9dcd892-14df-07d6-e053-2a95a90a0ceb
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lisinopril and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lisinopril and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 10
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
    Labeler Name Denton Pharma, Inc. dba Northwind Pharmaceuticals
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077912
    Listing Certified Through n/a

    Package

    NDC 70934-0717-30 (70934071730)

    NDC Package Code 70934-717-30
    Billing NDC 70934071730
    Package 30 TABLET in 1 BOTTLE, PLASTIC (70934-717-30)
    Marketing Start Date 2021-05-17
    NDC Exclude Flag N
    Pricing Information N/A